bThe peptidyl nucleoside arginomycin is active against Gram-positive bacteria and fungi but displays much lower toxicity to mice than its analog blasticidin S. It features a rare amino acid, -methylarginine, which is attached to the deoxyhexose moiety via a 4=-aminoacyl bond. We here report cloning of the complete biosynthetic gene cluster for arginomycin from Streptomyces arginensis NRRL 15941. Among the 14 putative essential open reading frames, argM, encoding an aspartate aminotransferase (AAT), and adjacent argN, encoding an S-adenosyl methionine (SAM)-dependent methyltransferase, are coupled to catalyze arginine and yield -methylarginine in Escherichia coli. Purified ArgM can transfer the ␣-amino group of L-arginine to ␣-ketoglutaric acid to give glutamate and thereby converts L-arginine to 5-guanidino-2-oxopentanoic acid, which is methylated at the C-3 position by ArgN to form 5-guanidino-3-methyl-2-oxopentanoic acid. Iteratively, ArgM specifically catalyzes transamination from the donor L-aspartate to the resulting 5-guanidino-3-methyl-2-oxopentanoic acid, generating -methylarginine. The complete and concise biosynthetic pathway for the rare and bioactive amino acid revealed by this study may pave the way for the production of -methylarginine either by enzymatic conversion or by engineered living cells.A rginomycin (Fig. 1) is a peptidyl nucleoside antibiotic isolated from Streptomyces arginensis NRRL 15941 that shows bioactivity against Gram-positive bacteria and fungi, such as Micrococcus luteus and Penicillium oxalicum (1). Although the overall skeleton of arginomycin is highly similar to that of blasticidin S (BS) (Fig. 1), a representative peptidyl nucleoside antibiotic exhibiting strong inhibitory activity against rice blast caused by Pyricularia oryzae Cavara (2), arginomycin showed much lower toxicity to mice (1). They differ from each other only in the modification of the L-arginine-derived guanidino side chain (Fig. 1). A feeding experiment indicated that -arginine in BS is derived from an intramolecular amino migration of ␣-arginine (3). BlsG, an arginine 2,3-aminomutase homologous to lysine 2,3-aminomutase (4), was assumed to govern this migration in the BS biosynthesis pathway. In contrast, ␦-N-methylation was demonstrated to be the ultrabiosynthetic step, as the conversion of demethylblasticidin S to BS was observed in a cell extract of the BS producer Streptomyces griseochromogenes supplied with radiolabeled S-adenosyl-L-methionine (SAM) (5). Likewise, ␦-N-methylation of the guanidyl group of arginomycin should also occur after attachment of the guanidino side chain to the nucleoside core moiety. In addition to this, arginomycin bears at the relatively unreactive  position of arginine the -methylarginine moiety for which -methylation is a commitment step and is of considerable interest to this study in uncovering new enzymology. There are two possibilities for the timing of the -methylation of arginine: (i) L-arginine is first converted to free -methylarginine and is coupled with ...